Adar Poonawalla

Adar Poonawalla has played a crucial role in the global fight against COVID-19 by leading the production of the Oxford-AstraZeneca vaccine, known as Covishield in India.

"As the first conjugate vaccine to safeguard against the five predominant causes of this deadly disease, MenFive offers hope for a future free from annual outbreaks and epidemics in the African meningitis belt. It is a big moment as we, together, pave the way towards a healthier Africa, saving countless lives," Poonawala said.

According to the authorities, he allegedly identified himself as the company's CEO, Adar Poonawalla, and sent a WhatsApp message to a director

SII CEO Adar Poonawalla said research is underway for monkeypox vaccine.

Taking to Twitter, Adar Poonawalla asked Elon Musk to invest in India. He assured Musk that it would be the best investment he would make

Covovax vaccination course consists of two separate doses of 0.5 ml each. After receiving one dose of the vaccine, the second dose should be administered after 3 weeks.

While India crossed the 100 crore vaccinations mark today, here is a list of 'experts' who had written off India's vaccination efforts, dismissed the 'Made In India' vaccines.

Serum Institute chairman Cyrus Poonawalla recalls the governmental and bureaucratic hurdles he faced during the UPA regime

Covishield vaccine is manufactured by the Serum Institute of India and developed by Oxford-AstraZeneca. AstraZeneca's EU-made vaccine Vaxzervria is included in the Green Pass.

Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals